Immunotherapy in upper gastrointestinal malignancies

Article Properties
Cite
Žiaran, Miroslav. “Immunotherapy in Upper Gastrointestinal Malignancies”. Onkologie, vol. 16, no. 3, 2022, pp. 123-6, https://doi.org/10.36290/xon.2022.024.
Žiaran, M. (2022). Immunotherapy in upper gastrointestinal malignancies. Onkologie, 16(3), 123-126. https://doi.org/10.36290/xon.2022.024
Žiaran M. Immunotherapy in upper gastrointestinal malignancies. Onkologie. 2022;16(3):123-6.
Refrences
Title Journal Journal Categories Citations Publication Date
Integrated genomic characterization of oesophageal carcinoma Nature
  • Science: Science (General)
 1,168 2017
SVOD
LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study Annals of Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 84 2020
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer JAMA Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 569 2020
10.1016/S0140-6736(21)01234-4